Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 113701-113750 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03191955
Muscle Wasting in Cancer (MWIC)
N/A
Active, not recruiting
120 participants
Started: Nov 26, 2015 · Completed: Aug 1, 2025
1 condition
3 sponsors
1 location
NCT02878967
Standardized Long Term Follow-up of Patients After Endovascular Embolization of a Brain Aneurysm
N/A
Recruiting
2,000 participants
Started: Nov 25, 2015 · Completed: Nov 24, 2030
1 condition
1 sponsor
1 location
NCT02615275
Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy
NA
Active, not recruiting
50 participants
Started: Nov 24, 2015 · Completed: Nov 30, 2026
1 condition
2 sponsors
1 location
NCT02612662
A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects
PHASE1
Active, not recruiting
40 participants
Started: Nov 24, 2015 · Completed: Aug 29, 2025
1 condition
1 sponsor
1 location
NCT03210935
French National Database of Rare Dermatological Cancers
N/A
Recruiting
9,000 participants
Started: Nov 24, 2015 · Completed: Dec 31, 2025
3 conditions
1 sponsor
34 locations
NCT02526264
Evaluation of Quality of Life and Period of Hospitalization by Education
NA
Recruiting
138 participants
Started: Nov 24, 2015 · Completed: Sep 30, 2025
1 condition
1 sponsor
2 locations
NCT03039439
Molecular and Immunohistochemical Profiling of Tumors in Patients with Parathyroid Tumors
N/A
Recruiting
310 participants
Started: Nov 24, 2015 · Completed: Nov 30, 2028
4 conditions
2 sponsors
1 location
NCT02339571
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
PHASE2/PHASE3
Recruiting
600 participants
Started: Nov 23, 2015 · Completed: Jun 30, 2033
2 conditions
1 sponsor
767 locations
NCT01905046
Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer
PHASE3
Active, not recruiting
86 participants
Started: Nov 23, 2015 · Completed: Nov 30, 2025
5 conditions
2 sponsors
27 locations
NCT02114450
Human-Machine System for the H2 Lower Limb Exoskeleton
NA
Recruiting
60 participants
Started: Nov 20, 2015 · Completed: Dec 31, 2029
2 conditions
3 sponsors
2 locations
NCT02337985
Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
PHASE1
Active, not recruiting
10 participants
Started: Nov 20, 2015 · Completed: Oct 2, 2025
6 conditions
2 sponsors
1 location
NCT04439331
Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U)
PHASE2
Active, not recruiting
35 participants
Started: Nov 19, 2015 · Completed: Dec 31, 2025
6 conditions
1 sponsor
1 location
NCT02579967
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
PHASE2
Recruiting
254 participants
Started: Nov 19, 2015 · Completed: Dec 31, 2036
5 conditions
1 sponsor
2 locations
NCT02568267
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
PHASE2
Active, not recruiting
534 participants
Started: Nov 19, 2015 · Completed: Dec 31, 2025
16 conditions
1 sponsor
128 locations
NCT02531516
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
PHASE3
Active, not recruiting
1,503 participants
Started: Nov 19, 2015 · Completed: Dec 29, 2028
1 condition
1 sponsor
262 locations
NCT03396224
Avenir® Cemented Hip Stem - PMCF
N/A
Active, not recruiting
100 participants
Started: Nov 18, 2015 · Completed: Nov 30, 2030
7 conditions
1 sponsor
3 locations
NCT04033757
A Population-based Cohort of Osteoarthritis: the Xiangya Osteoarthritis Study
N/A
Active, not recruiting
4,080 participants
Started: Nov 17, 2015 · Completed: Dec 31, 2031
1 condition
3 sponsors
1 location
NCT02531893
Psychological Treatments for Youth With Severe Irritability.
N/A
Recruiting
200 participants
Started: Nov 17, 2015 · Completed: May 8, 2028
1 condition
1 sponsor
1 location
NCT02686229
Registry Study on Epidemiological and Biological Disease Profile as Well as Clinical Outcome in Patients With Low Grade Gliomas
N/A
Recruiting
300 participants
Started: Nov 15, 2015 · Completed: Dec 31, 2036
1 condition
2 sponsors
1 location
NCT03065465
Standard Endoscopic Hemostasis Versus OVESCO Severe Non-variceal UGI Hemorrhage
NA
Recruiting
65 participants
Started: Nov 15, 2015 · Completed: Feb 28, 2025
1 condition
3 sponsors
2 locations
NCT02544022
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
N/A
Recruiting
486 participants
Started: Nov 13, 2015 · Completed: Dec 31, 2026
2 conditions
1 sponsor
6 locations
NCT02879123
Early Neurological Clinical Recovery, 3 Months After Endovascular Treatment of an Acute Ischemic Stroke
N/A
Recruiting
5,000 participants
Started: Nov 12, 2015 · Completed: May 12, 2031
1 condition
1 sponsor
1 location
NCT02293954
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
NA
Active, not recruiting
20 participants
Started: Nov 11, 2015 · Completed: Sep 11, 2025
12 conditions
2 sponsors
1 location
NCT02611427
Increasing Long-Term Physical Activity After Lumbar Spine Surgery
NA
Active, not recruiting
260 participants
Started: Nov 11, 2015 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT02480283
Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response
N/A
Recruiting
100 participants
Started: Nov 11, 2015 · Completed: Jul 31, 2027
2 conditions
2 sponsors
1 location
NCT02605486
Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
PHASE1/PHASE2
Active, not recruiting
46 participants
Started: Nov 11, 2015 · Completed: Nov 30, 2026
1 condition
2 sponsors
5 locations
NCT02656550
Uterine Transplantation and Pregnancy Induction in Women Affected by Absolute Uterine Infertility
NA
Active, not recruiting
20 participants
Started: Nov 11, 2015 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT02506153
Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
PHASE3
Active, not recruiting
1,301 participants
Started: Nov 10, 2015 · Completed: Jan 23, 2026
9 conditions
1 sponsor
578 locations
NCT02379429
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
N/A
Recruiting
500 participants
Started: Nov 10, 2015 · Completed: Jan 1, 2028
4 conditions
1 sponsor
1 location
NCT02677974
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
N/A
Active, not recruiting
510 participants
Started: Nov 10, 2015 · Completed: Aug 31, 2027
1 condition
2 sponsors
23 locations
NCT02276443
Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative
NA
Active, not recruiting
798 participants
Started: Nov 9, 2015 · Completed: Nov 30, 2026
12 conditions
2 sponsors
5 locations
NCT05600491
A Phase III Study of Postoperative Early Temozolomide Treatment Plus STUPP Regimen for Newly Diagnosed GBM Multiforme
PHASE3
Recruiting
78 participants
Started: Nov 8, 2015 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT03055247
Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD
PHASE2
Recruiting
3 participants
Started: Nov 6, 2015 · Completed: Jul 18, 2026
1 condition
2 sponsors
2 locations
NCT02504372
Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091)
PHASE3
Active, not recruiting
1,177 participants
Started: Nov 6, 2015 · Completed: Jan 21, 2026
1 condition
3 sponsors
0 locations
NCT03409133
Feasibility of Neural Feedback for Lower Limb Amputees
NA
Recruiting
15 participants
Started: Nov 5, 2015 · Completed: Sep 1, 2027
1 condition
3 sponsors
1 location
NCT03048266
Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
N/A
Recruiting
629 participants
Started: Nov 5, 2015 · Completed: Nov 1, 2026
1 condition
1 sponsor
1 location
NCT02506933
Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant
PHASE2
Active, not recruiting
102 participants
Started: Nov 5, 2015 · Completed: Jun 9, 2026
13 conditions
3 sponsors
3 locations
NCT02402244
Project: Every Child for Younger Patients With Cancer
N/A
Recruiting
75,000 participants
Started: Nov 3, 2015 · Completed: Dec 31, 2030
18 conditions
2 sponsors
273 locations
NCT02542293
Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)
PHASE3
Active, not recruiting
953 participants
Started: Nov 3, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
210 locations
NCT04224025
Training Single Arm
NA
Recruiting
250 participants
Started: Nov 3, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02392572
ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome
PHASE1/PHASE2
Recruiting
120 participants
Started: Nov 3, 2015 · Completed: Nov 30, 2026
6 conditions
2 sponsors
1 location
NCT03620032
Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses
PHASE2
Active, not recruiting
54 participants
Started: Nov 2, 2015 · Completed: Nov 2, 2024
1 condition
5 sponsors
1 location
NCT02516241
Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer
PHASE3
Active, not recruiting
1,126 participants
Started: Nov 2, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
222 locations
NCT02445222
CAR-T Long Term Follow Up (LTFU) Study
PHASE3
Recruiting
1,400 participants
Started: Nov 2, 2015 · Completed: Feb 22, 2036
1 condition
2 sponsors
109 locations
NCT02655744
Prospective Neurobehavioral Outcomes Follow-up in Primary CNS Lymphoma Patients Treated With Cranial Radiotherapy Combined With or Without MTX-based Chemotherapy According to the Multidisciplinary Treatment Guidelines Implemented at a Single Institute
N/A
Recruiting
25 participants
Started: Nov 1, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02547987
Neoadjuvant Carboplatin and Docetaxel in Triple Negative Breast Cancer
PHASE2
Active, not recruiting
25 participants
Started: Nov 1, 2015 · Completed: Sep 30, 2025
1 condition
1 sponsor
3 locations
NCT03343236
Nutrition and Inflammation in Patients with Head and Neck Cancer
N/A
Active, not recruiting
522 participants
Started: Nov 1, 2015 · Completed: Dec 31, 2027
4 conditions
4 sponsors
1 location
NCT04415515
Standard Care Coordination Expansion Pilot
NA
Recruiting
592,023 participants
Started: Oct 31, 2015 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT02736669
CARE Trial: Comparing Different Levels of Calorie Reduction for Weight Loss
NA
Active, not recruiting
223 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT02555735
Exceptional Responders With Solid Tumor Cancer to Chemotherapy
N/A
Enrolling by invitation
250 participants
Started: Oct 31, 2015 · Completed: Aug 31, 2027
1 condition
2 sponsors
1 location
Previous
1
More pages
2272
2273
2274
2275
2276
2277
2278
More pages
2369
Next